Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-06 Purchase |
2021-01-08 8:31 pm |
EYEGATE PHARMACEUTICALS INC | EYEG | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
1,531,101 | $5.225 | $8,000,003 | 15,864,568 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-01 Option Award |
2021-02-03 9:51 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | MALFROY-CAMINE BERNARD Director |
3,333 | $0 | 3,333 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:51 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | GOLDBERG MORTON Director |
3,333 | $0 | 3,333 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:50 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | Obermayr Franz Acting CEO |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-02-03 9:50 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Obermayr Franz Acting CEO |
0 | $0 | 101,613 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-05 4:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO |
705 | $4.85 | 77,288 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-05 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
115 | $4.85 | 25,613 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-05 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
115 | $4.85 | 17,292 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-05 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
115 | $4.85 | 17,256 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-08 8:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
91 | $3.76 | 17,371 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-08 8:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO |
588 | $3.76 | 77,993 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-08 8:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
91 | $3.76 | 17,407 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-08 8:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
91 | $3.76 | 25,728 (Direct) |
View |
| 2020-11-02 Tax Withholding |
2020-11-03 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO |
623 | $3.51 | 78,581 (Direct) |
View |
| 2020-11-02 Tax Withholding |
2020-11-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
96 | $3.51 | 17,462 (Direct) |
View |
| 2020-11-02 Tax Withholding |
2020-11-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
97 | $3.51 | 25,819 (Direct) |
View |
| 2020-11-02 Tax Withholding |
2020-11-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
97 | $3.51 | 17,498 (Direct) |
View |
| 2020-10-02 Tax Withholding |
2020-10-05 5:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO |
631 | $3.88 | 79,204 (Direct) |
View |
| 2020-10-02 Tax Withholding |
2020-10-05 5:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
98 | $3.88 | 17,595 (Direct) |
View |
| 2020-10-02 Tax Withholding |
2020-10-05 5:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
98 | $3.88 | 25,916 (Direct) |
View |
| 2020-10-02 Tax Withholding |
2020-10-05 5:56 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
98 | $3.88 | 17,558 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 5:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO |
628 | $3.94 | 79,835 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 5:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
97 | $3.94 | 17,656 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 5:30 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
97 | $3.94 | 17,693 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 5:30 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
97 | $3.94 | 26,014 (Direct) |
View |
| 2020-08-04 Tax Withholding |
2020-08-05 5:12 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
95 | $4.11 | 26,111 (Direct) |
View |
| 2020-08-04 Tax Withholding |
2020-08-05 5:12 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO |
615 | $4.11 | 80,463 (Direct) |
View |
| 2020-08-04 Tax Withholding |
2020-08-05 5:11 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
95 | $4.11 | 17,790 (Direct) |
View |
| 2020-08-04 Tax Withholding |
2020-08-05 5:11 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
92 | $4.11 | 17,753 (Direct) |
View |
| 2020-07-02 Tax Withholding |
2020-07-06 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO 10% Owner |
625 | $4.82 | 81,078 (Direct) |
View |
| 2020-07-02 Tax Withholding |
2020-07-06 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
97 | $4.82 | 17,885 (Direct) |
View |
| 2020-07-02 Tax Withholding |
2020-07-06 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
97 | $4.82 | 26,206 (Direct) |
View |
| 2020-07-02 Tax Withholding |
2020-07-06 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
94 | $4.82 | 17,845 (Direct) |
View |
| 2020-06-03 Tax Withholding |
2020-06-04 4:18 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN President and CEO |
627 | $5.11 | 81,703 (Direct) |
View |
| 2020-06-03 Tax Withholding |
2020-06-04 4:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
94 | $5.11 | 26,303 (Direct) |
View |
| 2020-06-03 Tax Withholding |
2020-06-04 4:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
94 | $5.11 | 17,939 (Direct) |
View |
| 2020-06-03 Tax Withholding |
2020-06-04 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
94 | $5.11 | 17,982 (Direct) |
View |
| 2020-05-05 Tax Withholding |
2020-05-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
93 | $5.1 | 26,397 (Direct) |
View |
| 2020-05-05 Tax Withholding |
2020-05-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
113 | $5.1 | 18,033 (Direct) |
View |
| 2020-05-05 Tax Withholding |
2020-05-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | MANZO MICHAEL P. VP of Engineering |
93 | $5.1 | 18,076 (Direct) |
View |